Key Insights into the Hereditary Cancer Testing Market: Trends, Growth Rate, and Opportunities Through 2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theHereditary Cancer Testing Market?
The escalating incidence of inherited cancers is anticipated to fuel the market for hereditary cancer testing. Genes carrying certain mutations, which are transmitted from parents to offspring, trigger inherited cancer syndromes. Tests for this type of cancer can identify these specific, inheritable mutations related to the disease, thereby offering a complete risk evaluation for cancer in patients. For example, in June 2022, an article on BioMed Central concerning clinical practices for inherited cancer stated approximately 10% of pancreatic cancer instances have a genetic aspect. Consequently, the surging instances of hereditary cancer provoke the expansion of the market for inherited cancer testing.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8121&type=smp
#What is the Anticipated CAGR of theHereditary Cancer Testing Market, and What Factors Will Drive It?
The market size of hereditary cancer testing has seen swift expansion in the recent past. From $4.32 billion in 2024, it is predicted to climb to $4.78 billion by 2025, showcasing a compound annual growth rate (CAGR) of 10.8%. A number of factors have contributed to this historic growth, such as an increase in cases of hereditary cancers, the initiation of genetic counseling programs, proactive government prevention measures against cancer, enhanced insurance coverage, and a deeper understanding of the interplay between genes and environment. In addition, patient advocacy and support groups have also played a significant role.
Expectations are high for the hereditary cancer testing market to experience significant growth in the upcoming years, with projections indicating a surge to $7.37 billion by 2029, courtesy of a compound annual growth rate (CAGR) of 11.4%. This projected growth within the forecast period is likely due to several factors, including the broadening scope of targeted therapies, the progress of precision medicine, and an increase in direct-to-consumer testing. Other contributing factors include international health programs and advancements in the field of bioinformatics. Some key trends to watch during this period consist of progressing genetic sequencing technologies, the adoption of telemedicine and remote genetic therapy, personalized medicine and treatment, cancer risk evaluation models and the impacts of ethical and legal considerations.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8121
What Are the Current Market Growth and Trends in theHereditary Cancer Testing Market That Industry Players Should Watch?
The rise of technological advancements is a significant trend that is catching on in the hereditary cancer testing market. The main market players are capitalizing on these technological innovations to maintain their dominance in the market. For example, in March 2022, Myriad Genetics, a leading genetic testing and precision medicine organization based in the US, rolled out genetic testing that includes a Polygenic Breast Cancer Risk Assessment Score for individuals of all ancestries. This particular MyRisk Hereditary Cancer test with RiskScore extends to offer a custom breast cancer risk analysis to all women who have never received a breast cancer diagnosis, irrespective of their ancestry.
What Are the Major Market Players Making an Impact on theHereditary Cancer Testing Market Growth?
Major companies operating in the hereditary cancer testing market are Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report
How Are the Key Segments of the Hereditary Cancer Testing Market Driving Opportunities and Innovations?
The hereditary cancer testing market covered in this report is segmented –
1) By Test Type: Multi Panel Test, Single-Site Genetic Test
2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications
3) By End user: Hospital, Clinics, Diagnostic Centers
Subsegments:
1) By Multi Panel Test: Comprehensive Genetic Panels, Targeted Gene Panels
2) By Single-Site Genetic Test: Specific Gene Testing, Familial Mutation Testing
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8121&type=smpGlobal Hereditary Cancer Testing Market, Global Hereditary Cancer Testing Market Report, Global Hereditary Cancer Testing Market Trends, Global Hereditary Cancer Testing Market Size
Browse Through More Reports Similar to the Gobal Hereditary Cancer Testing Maret 2025, By The Business Research Company:
Analytical Standards Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/analytical-standards-global-market-report
Healthcare Analytical Testing Services Global Market Report 2024
Analytical Laboratory Instrument Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
